Serrated carcinomas form a subclass of colorectal cancer with distinct molecular basis

[1]  N. Goldstein.  Serrated pathway and APC (conventional)-type colorectal polyps: molecular-morphologic correlations, genetic pathways, and implications for classification. , 2006, American journal of clinical pathology.

[2]  Andrew J. Wilson,et al.  Mechanisms of inactivation of the receptor tyrosine kinase EPHB2 in colorectal tumors. , 2005, Cancer research.

[3]  A. Liakka,et al.  Morphology and microsatellite instability in sporadic serrated and non‐serrated colorectal cancer , 2005, The Journal of pathology.

[4]  C. Boland,et al.  Serrated Adenomas Have a Pattern of Genetic Alterations That Distinguishes Them from Other Colorectal Polyps , 2005, Cancer Epidemiology Biomarkers & Prevention.

[5]  J. Astola,et al.  Gene-expression profiling predicts recurrence in Dukes' C colorectal cancer. , 2005, Gastroenterology.

[6]  T. Pawson,et al.  EphB receptor activity suppresses colorectal cancer progression , 2005, Nature.

[7]  M. Mäkinen,et al.  The risk of metachronous neoplasia in patients with serrated adenoma. , 2005, American journal of clinical pathology.

[8]  J. Pouysségur,et al.  Transcriptional regulation of the Vascular Endothelial Growth Factor gene--a concert of activating factors. , 2005, Cardiovascular research.

[9]  Christopher Lawrence.  Pathology , 1911, The Lancet.

[10]  Tony Pawson,et al.  Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancer , 2004, Nature Genetics.

[11]  N. Matsubara,et al.  BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum , 2004, Gut.

[12]  J. Jass,et al.  My approach to serrated polyps of the colorectum , 2004, Journal of Clinical Pathology.

[13]  Cancer Epidemiol Biomarkers Prev , 2004 .

[14]  G. Semenza.  Targeting HIF-1 for cancer therapy , 2003, Nature Reviews Cancer.

[15]  Tsung-Teh Wu,et al.  Frequent CpG island methylation in serrated adenomas of the colorectum. , 2003, The American journal of pathology.

[16]  May D. Wang,et al.  GoMiner: a resource for biological interpretation of genomic and proteomic data , 2003, Genome Biology.

[17]  J. Mullor,et al.  Pathways and consequences: Hedgehog signaling in human disease. , 2002, Trends in cell biology.

[18]  Long-Cheng Li,et al.  MethPrimer: designing primers for methylation PCRs , 2002, Bioinform..

[19]  Tony Pawson,et al.  β-Catenin and TCF Mediate Cell Positioning in the Intestinal Epithelium by Controlling the Expression of EphB/EphrinB , 2002, Cell.

[20]  B. Leggett,et al.  Emerging concepts in colorectal neoplasia. , 2002, Gastroenterology.

[21]  E. Sawyer,et al.  Molecular characteristics of serrated adenomas of the colorectum , 2002, Gut.

[22]  K. Kullander,et al.  Mechanisms and functions of eph and ephrin signalling , 2002, Nature Reviews Molecular Cell Biology.

[23]  Jeffrey S. Morris,et al.  Concordant CpG island methylation in hyperplastic polyposis. , 2002, The American journal of pathology.

[24]  Y. Miura,et al.  Apoptosis Index and Apoptosis-Related Antigen Expression in Serrated Adenoma of the Colorectum: The Saw-Toothed Structure May Be Related to Inhibition of Apoptosis , 2002, The American journal of surgical pathology.

[25]  Adrian L. Harris,et al.  Hypoxia — a key regulatory factor in tumour growth , 2002, Nature Reviews Cancer.

[26]  R. Ward,et al.  Sporadic colorectal cancers with microsatellite instability and their possible origin in hyperplastic polyps and serrated adenomas. , 2001, Journal of the National Cancer Institute.

[27]  J. Taipale,et al.  The Hedgehog and Wnt signalling pathways in cancer , 2001, Nature.

[28]  P. Vihko,et al.  Colorectal carcinoma associated with serrated adenoma – prevalence, histological features, and prognosis , 2001, The Journal of pathology.

[29]  A. Rashid,et al.  Phenotypic and molecular characteristics of hyperplastic polyposis. , 2000, Gastroenterology.

[30]  L. Aaltonen,et al.  Population-based molecular detection of hereditary nonpolyposis colorectal cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[32]  J. Mesirov,et al.  Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.

[33]  J. Mesirov,et al.  Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[34]  B. Leggett,et al.  DNA microsatellite instability in hyperplastic polyps, serrated adenomas, and mixed polyps: a mild mutator pathway for colorectal cancer? , 1999, Journal of clinical pathology.

[35]  L. Aaltonen,et al.  Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. , 1998, The New England journal of medicine.

[36]  J. Herman,et al.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Michael Dean,et al.  Mutations of the Human Homolog of Drosophila patched in the Nevoid Basal Cell Carcinoma Syndrome , 1996, Cell.

[38]  R. Myers,et al.  Human Homolog of patched, a Candidate Gene for the Basal Cell Nevus Syndrome , 1996, Science.

[39]  A. Mccarthy.  Development , 1996, Current Opinion in Neurobiology.

[40]  D. S. Prestridge.  Predicting Pol II promoter sequences using transcription factor binding sites. , 1995, Journal of molecular biology.

[41]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[42]  C. Fenoglio-Preiser,et al.  Mixed Hyperplastic Adenomatous Polyps/Serrated Adenomas: A Distinct Form of Colorectal Neoplasia , 1990, The American journal of surgical pathology.

[43]  I. Forgacs.  GASTROENTEROLOGY , 1988, The Lancet.

[44]  R. Schwartz,et al.  Basal-cell-nevus syndrome and gastrointestinal polyposis. , 1978, The New England journal of medicine.